SEQUENT

Viyash Scientific Ltd.

NSE: VIYASH

BSE: 512529

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

229.07-2.7 (-1.16%)

5 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

82.8 / 100

Value Score

22.1 / 100

Price Momentum Score

69.6 / 100

QVM Score

64.5 / 100

Key Metrics

Market Cap

10106.90

P/E (TTM)

59.05

P/B

3.47

P/S (TTM)

3.21

EV/EBITDA

17.21

CAPE (5Y)

1477.87

ROE (TTM)

9.81

ROCE (TTM)

17.32

ROA (TTM)

5.69

Avg 3Y ROE

2.58

Earnings 3Y CAGR

Sales 3Y CAGR

30.62

Sales 5Y CAGR

18.08

Debt/Equity

0.17

Consensus TP

320.00

Strong Buy %

100.00

Promoter Holding

61.31

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Viyash Scientific Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Moderate operating margin but improving trend

The company reported moderate operating margin of 12.85% for 12-month ended 30 Jun 2026 but operating margin improved by 665 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 96.48% for 12-month ended 30 Jun 2026 and the growth was 85.8 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 96.48

-99.6111701.8

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 251.43% for 12-month ended 30 Jun 2026 and the growth was 243.98 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low and declining Debt to Equity

The company has low Debt to Equity of 0.17 as on 30 Jun 2026 and Debt to Equity decreased by 0.51 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 74.8 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

74.8 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 59.05 indicates that the stock is expensive on a standalone basis and is at a 87.82% premium to industry median P/E

What is P/E Ratio?

Median: 31.44

Value 59.05

-0.84721.21

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -5.79% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of 9.81% for 12-month ended 30 Jun 2026 but ROE improved by 659 bps from 1 year ago

What is ROE (FY)?

Financial Snapshot

See detailed analysis

Multi-year trends for Viyash Scientific Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Viyash Scientific Ltd. Shareholding Pattern

Quarterly breakdown of Viyash Scientific Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	56.15	54.87	54.51	53.86	53.86	53.86	53.52	53.02	53.02	52.79	52.79	52.79	52.79	52.79	52.79	52.79	52.79	52.78	52.76	52.61	52.61	52.61	52.33	61.41	61.31	61.31
Indian Promoter	56.15	54.87	1.49	0.84	0.84	0.84	0.50	-	-	-	-	-	-	-	-	-	-	52.78	-	-	-	-	-	-	-	-
Foreign Promoter	-	-	53.02	53.02	53.02	53.02	53.02	53.02	53.02	52.79	52.79	52.79	52.79	52.79	52.79	52.79	52.79	-	52.76	52.61	52.61	52.61	52.33	61.41	61.31	61.31
Institutions	12.55	11.63	13.12	14.84	16.36	16.09	16.15	8.55	7.88	8.72	9.36	9.06	8.82	9.18	9.26	13.34	13.75	13.76	16.44	18.10	18.86	19.14	18.82	10.52	10.93	8.25
Mutual Funds / UTI	3.79	4.06	4.64	4.51	2.68	2.10	1.49	0.51	0.30	0.29	0.45	0.25	0.25	0.25	1.03	5.02	5.16	5.69	7.41	9.58	10.22	10.08	10.04	5.82	6.44	2.93
FI/Bank/Insurance	0.21	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.22	1.21	1.21	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	8.55	7.49	8.37	10.20	13.15	13.60	14.12	6.42	5.84	6.45	6.57	6.25	5.89	6.27	6.03	6.11	6.16	5.69	6.45	6.10	6.05	6.15	5.90	3.16	2.94	4.50
Other Institutions	0.00	0.02	0.10	0.14	0.53	0.38	0.55	1.62	1.73	1.97	1.12	1.35	1.46	1.92	2.20	2.21	2.43	2.37	2.58	2.42	2.59	2.90	2.87	1.54	1.54	0.83
Non-Institution	31.30	33.51	32.37	31.30	29.77	30.06	30.33	38.43	39.11	38.49	37.86	38.15	38.39	38.03	37.96	33.86	33.46	33.46	30.80	29.29	28.53	28.26	28.85	28.06	27.76	30.43
Bodies Corporate	11.28	13.99	10.31	9.51	6.92	6.67	7.17	8.39	7.86	7.23	7.03	6.85	6.57	6.48	5.92	6.32	6.50	5.94	4.20	2.92	2.67	3.36	3.39	2.51	3.28	4.55
Others (incl. Retail) No. of shareholders	20.02 15,520	19.52 18,623	22.06 37,187	21.79 46,014	22.85 61,649	23.39 86,096	23.16 1,23,115	30.04 1,66,711	31.25 1,89,918	31.26 1,95,973	30.83 1,92,771	31.30 1,95,133	31.82 1,90,851	31.55 1,86,479	32.04 1,83,613	27.54 1,72,002	26.96 1,65,770	27.52 1,62,897	26.60 1,53,681	26.37 1,61,574	25.86 1,57,181	24.90 1,46,435	25.46 1,43,177	25.55 1,33,391	24.48 1,26,698	25.88 1,27,546

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Microcap 250	0.43%	73 / 250
2	Nifty Total Market	0.02%	530 / 749

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Viyash Scientific Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Sequent Scientific Employee Stock Plan Trust Other	December-2023	Market Sale (Disposal) 26th Dec 2023	0.38 %	₹ 115.12	5.50 lac	₹ 6.33 cr
Manish Gupta Director	April-2022	Market Sale (Disposal) 4th Apr 2022	0.26 %	₹ 133.95	2.91 lac	₹ 3.90 cr
Manish Gupta Director	April-2022	Market Sale (Disposal) 4th Apr 2022	0.14 %	₹ 138.44	1.03 lac	₹ 1.43 cr
Manish Gupta Director	April-2022	Market Sale (Disposal) 4th Apr 2022	0.09 %	₹ 136.48	52.63 k	₹ 71.83 lac
Manish Gupta Director	April-2022	Market Sale (Disposal) 4th Apr 2022	0.29 %	₹ 130.12	98.03 k	₹ 1.28 cr
Manish Gupta Director	March-2022	Market Sale (Disposal) 25th Mar 2022	0.46 %	₹ 133.03	3.00 lac	₹ 3.99 cr
Manish Gupta Director	March-2022	Market Sale (Disposal) 25th Mar 2022	0.60 %	₹ 124.16	66.42 k	₹ 82.47 lac
Manish Gupta Director	March-2022	Market Sale (Disposal) 25th Mar 2022	0.57 %	₹ 124.12	2.87 lac	₹ 3.56 cr
Manish Gupta Director	March-2022	Market Sale (Disposal) 11th Mar 2022	0.62 %	₹ 125.20	54.23 k	₹ 67.90 lac
Manish Gupta Director	March-2022	Market Sale (Disposal) 11th Mar 2022	0.62 %	₹ 124.08	6.32 k	₹ 7.84 lac

…

Corporate Actions

History of Viyash Scientific Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.50/share
Record date: 10th Sep 2021Ex-date: 8th Sep 2021
Announced on: 30th Jun 2021
Dividend₹ 0.20/share
Record date: 22nd Aug 2019Ex-date: 21st Aug 2019
Announced on: 14th May 2019
Others
Ex-date: 6th Apr 2018Announced on: 26th Mar 2018
Demerger of the Human API Business into Solara Active Pharma sciences limited.
Dividend₹ 0.20/share
Record date: 21st Nov 2017Ex-date: 20th Nov 2017
Announced on: 9th Nov 2017
Stock Split1 : 5
Ex-date: 25th Feb 2016Announced on: 29th Oct 2015
Nominal value change from INR 10 to INR 2.

Company Profile

Overview of Viyash Scientific Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has...

Key personnel

Mr. Ramakant Singani

Chief Financial Officer

Ms. Yoshita Susmit Vora

Company Secretary, Compliance Officer

Mr. Prasad Lad

Vice President - Human Resources and Admin

Mr. Nrusimha Srinivasa Rao Bondalapati

Vice President - Quality & Regulatory

Mr. Pankaj Lohan

Vice President, Head - India Formulations

Mr. Attanti Veera Venkata Srinivasa Rao

Vice President - Research & Development (API)

Mr. Alexis Goux

Head - Global Formulations

Mr. Peddanna Gumudavelli

Chief Operating Officer - Appco Pharma LLC, US

View all

Incorporated on

28 Jun 1985

Last Annual

Last Interim

30 Jun 2026

No. of Employees

IPO date

10 Mar 2016

Free Float

19,58,34,984

Website

https://sequent.in/

Phone no.

+912268534777

Address

3rd Floor, Srivallis Corporate, Plot No. 290, SYN 33 34 PTO 39, Guttala Begumpet, Jubilee Hills,Shaikpet, HYDERABAD, 500033, India

Frequently Asked Questions

What is the current share price of Viyash Scientific Ltd.?

The current share price of Viyash Scientific Ltd. is ₹ 229.07 as of 5 Oct 2026.

What is the market capitalisation of Viyash Scientific Ltd.?

The market capitalisation of Viyash Scientific Ltd. stands at ₹ 10,106.90 Cr.

What is the PE ratio of Viyash Scientific Ltd.?

The Price-to-Earnings (PE) ratio of Viyash Scientific Ltd. is 59.05 as of the latest trailing twelve months data.

What is the ROE and ROCE of Viyash Scientific Ltd.?

Viyash Scientific Ltd. has a Return on Equity (ROE) of 9.81% and a Return on Capital Employed (ROCE) of 17.32% as per the latest financial reports.

What is the 52-week high and low of Viyash Scientific Ltd.?

The 52-week high of Viyash Scientific Ltd. is - and the 52-week low is -.

What is the dividend yield of Viyash Scientific Ltd.?

The dividend yield of Viyash Scientific Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Viyash Scientific Ltd.?

Foreign Institutional Investors (FII) hold 4.50%, Domestic Institutional Investors (DII) hold 2.93% and retail/public investors hold 25.88% of Viyash Scientific Ltd. shares.

What sector does Viyash Scientific Ltd. belong to?

Viyash Scientific Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Viyash Scientific Ltd. with a consensus target price of ₹ 320.00, implying 39.7% upside from current levels.

What is the beta of Viyash Scientific Ltd.?

The beta of Viyash Scientific Ltd. is 1.38, indicating its price volatility relative to the broader market. Over the past 1 year, Viyash Scientific Ltd. has delivered an absolute return of 17.97%.

What is the RSI of Viyash Scientific Ltd.?

The 14-day Relative Strength Index (RSI) of Viyash Scientific Ltd. is 30.18, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Viyash Scientific Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Viyash Scientific Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile

Holdings and Presence